Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.

Harding SA, Sarma J, Josephs DH, Cruden NL, Din JN, Twomey PJ, Fox KA, Newby DE.

Circulation. 2004 Apr 27;109(16):1926-9. Epub 2004 Apr 12.

2.

Effects of alimentary lipemia and inflammation on platelet CD40-ligand.

Kälsch T, Elmas E, Nguyen XD, Kralev S, Leweling H, Klüter H, Dempfle CE, Borggrefe M.

Thromb Res. 2007;120(5):703-8. Epub 2007 Feb 6.

PMID:
17289125
3.

Upregulation of platelet CD40, CD40 ligand (CD40L) and P-Selectin expression in cigarette smokers: a flow cytometry study.

Neubauer H, Setiadi P, Pinto A, Günesdogan B, Meves SH, Börgel J, Mügge A.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):694-8. doi: 10.1097/MBC.0b013e328331e6f2.

PMID:
19734779
4.

Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.

Amirkhosravi A, Amaya M, Desai H, Francis JL.

Blood Coagul Fibrinolysis. 2002 Sep;13(6):505-12.

PMID:
12192302
5.
6.

Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus.

Harding SA, Sommerfield AJ, Sarma J, Twomey PJ, Newby DE, Frier BM, Fox KA.

Atherosclerosis. 2004 Oct;176(2):321-5.

PMID:
15380455
7.

Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetes.

Neubauer H, Setiadi P, Günesdogan B, Pinto A, Börgel J, Mügge A.

Diabet Med. 2010 Apr;27(4):384-90. doi: 10.1111/j.1464-5491.2010.02957.x.

PMID:
20536508
8.

Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.

Mason PJ, Chakrabarti S, Albers AA, Rex S, Vitseva O, Varghese S, Freedman JE.

Am J Cardiol. 2005 Nov 15;96(10):1365-9. Epub 2005 Sep 19.

PMID:
16275179
9.

Homocysteine modulates the CD40/CD40L system.

Prontera C, Martelli N, Evangelista V, D'Urbano E, Manarini S, Recchiuti A, Dragani A, Passeri C, Davì G, Romano M.

J Am Coll Cardiol. 2007 Jun 5;49(22):2182-90. Epub 2007 May 18.

10.

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.

Schönbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P.

Circulation. 2002 Dec 3;106(23):2888-93.

11.

Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus.

Jinchuan Y, Zonggui W, Jinming C, Li L, Xiantao K.

Clin Chim Acta. 2004 Jan;339(1-2):85-90.

PMID:
14687897
12.

Flow cytometric investigation of CD40-CD40 ligand system in preeclampsia and normal pregnancy.

Lukanov TH, Bojinova SI, Popova VS, Emin AL, Veleva GL, Gecheva SP, Konova EI.

Clin Appl Thromb Hemost. 2010 Jun;16(3):306-12. doi: 10.1177/1076029608331229. Epub 2009 Feb 15.

PMID:
19221099
13.

Increased levels of CD40-CD40 ligand system in patients with essential hypertension.

Yan JC, Ma GS, Wu ZG, Kong XT, Zong RQ, Zhan LZ.

Clin Chim Acta. 2005 May;355(1-2):191-6.

PMID:
15820495
14.

Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.

Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1626-31. Epub 2006 Apr 6.

15.

TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A, Piqué JM, Panes J, Katz JA, Gasbarrini A, Fiocchi C.

J Immunol. 2006 Feb 15;176(4):2617-24.

16.

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.

Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L.

Circulation. 1999 Aug 10;100(6):614-20.

17.
18.

P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.

Zhao L, Bath PM, May J, Lösche W, Heptinstall S.

Platelets. 2003 Nov-Dec;14(7-8):473-80. Erratum in: Platelets. 2004 Feb;15(1):63.

PMID:
14713516
19.

Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.

Kälsch T, Elmas E, Nguyen XD, Suvajac N, Klüter H, Borggrefe M, Dempfle CE.

Basic Res Cardiol. 2007 Sep;102(5):460-6. Epub 2007 Jul 13.

PMID:
17624488
20.

Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression.

Lindmark E, Tenno T, Siegbahn A.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2322-8.

Supplemental Content

Support Center